Beyond mRNA Vaccines: What's the Next Frontier?
Ever wondered why Moderna is diving into rare disease therapies? Find out the intriguing story behind their bold move! Plus, discover how mRNA therapy is revolutionizing the development of treatments for rare diseases.
We have an exclusive interview with Dr. Paolo Martini, Chief Scientific Officer of Moderna's Rare Disease Division.
Don't miss out, dive into the full report now!
https://lnkd.in/gQwd3nRa
Visit #GlobalBio for more information about mRNA therapy:
https://lnkd.in/gN4wNqj2
#RareDiseaseBreakthroughs #mRNA
Beyond mRNA Vaccines: What's the Next Frontier?
撰文GlobalBio & Investment
日期2023-12-01
![](/upload/article/_images/1702901639834.jpg)
Beyond mRNA Vaccines: What's the Next Frontier?